[Prevention of hemolytic disease of the newborn with human anti-RH-D immunoglobulin].
D000017:ABO Blood-Group System; D000022:Abortion, Spontaneous; D001787:Blood Group Incompatibility; D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005260:Female; D005331:Fetomaternal Transfusion; D006801:Humans; D006814:Hungary; D007106:Immune Sera / Q000302:isolation & purification; D007074:Immunoglobulin G / Q000627:therapeutic use; D007231:Infant, Newborn; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System; D005719:gamma-Globulins / Q000008:administration & dosage / Q000627:therapeutic use*
D000017:ABO Blood-Group System; D007106:Immune Sera; D007074:Immunoglobulin G; D012204:Rh-Hr Blood-Group System; D005719:gamma-Globulins
Prévention de la maladie hémolytique néo-natale par l'immunoglobine anti-RH-D humaine.